Latest News about ZEAL
Recent news which mentions ZEAL
With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?
April 12, 2021
From Motley Fool
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
March 27, 2021
From Benzinga
From Benzinga
From Benzinga
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
March 20, 2021
From Benzinga
60 Stocks Moving In Monday's Mid-Day Session
March 01, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 01, 2021
From Benzinga
38 Stocks Moving in Monday's Pre-Market Session
March 01, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
February 28, 2021
From Benzinga
Earnings Scheduled For November 12, 2020
November 12, 2020
From Benzinga
9 Biotech Stocks With Material Catalysts In Q4
October 13, 2020
From Benzinga
From Benzinga
40 Stocks Moving in Tuesday's Pre-Market Session
October 06, 2020
From Benzinga
Zealand Pharma A/S (ZEAL) Q2 2020 Earnings Call Transcript
August 14, 2020
Tickers
ZEAL
From Motley Fool
62 Biggest Movers From Yesterday
June 19, 2020
From Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
June 18, 2020
From Benzinga
From Benzinga
40 Stocks Moving in Thursday's Pre-Market Session
June 18, 2020
From Benzinga
From Benzinga
8 Stocks To Watch For May 26, 2020
May 26, 2020
From Benzinga
Tickers
ZEAL
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
March 27, 2020
From Benzinga
Zealand Pharma A/S (ZEAL) Q4 2019 Earnings Call Transcript
March 12, 2020
Tickers
ZEAL
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
February 14, 2020
From Benzinga
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
February 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 13, 2020
From Benzinga
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
February 13, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.